Leanings In The Biopharma Contract Manufacturing For 2022

Here are the main trends in outsourcing manufacturing of biopharmaceuticals, which are becoming more important part of the drug development process and market.

By 2026, Pharma Contract Manufacturing To Be Worth $130bn

In 2020, the global pharmaceutical contract manufacturing market was estimated to be worth $100 billion and is anticipated to reach $130.2 billion by 2026.

Formulation Development Offshore Market To Be $60bn By 2030

Growing at a CAGR of 7.2%, the global formulation development outsourcing market will increase from its value of $35.1 billion in 2022 to $61.4 billion by 2030

CRISIL Predicts Indian Pharma Sales To Rise 7%-9% In FY23

Because of the difficulties in export sales in controlled markets, the Indian pharmaceutical industry expects a moderate revenue growth of 7-9% in the current fiscal.

FDA Warning Letters List Typical Pharma Regulatory Issues

Reviewing FDA warning letters from past 10 years reveals that manufacturing process validation, quality control, data record and integrity are most essential.

Moderna Sues Pfizer, BioNTech Over mRNA COVID-19 Vaccines

Pfizer, BioNTech are accused of using Moderna-patented mRNA vaccine technologies in the production of Comirnaty COVID-19 jab without any permission from them.